GET A VALUABLE CERTIFICATE FOR JOB MARKET


ACADEMIC RECOGNITION OF 3 OR 6 CREDITS


DESIGNED FOR EXPERTS BY EXPERTS


DRUG UTILISATION STUDIES: INTRODUCTION AND QUANTITATIVE METHODS


OBJECTIVES



To understand the need to study how medicines are used.

To describe the general characteristics of the different methods to study the use of medicines, and to identify them.

To know the different methods and measures that allow quantitative approach to medicines utilisation.

To carry out critical appraisal of quantitative drug utilisation studies.

To design, to carry out and to analyze quantitative studies of medicines utilisation in different clinical settings.

Consumption, market, DDD, sales, appraisal

 

MODULE PARTS



  1. Measurement of drug use
  2. Overview of drug utilisation studies (DUS)
  3. Quantitative measures of drug utilisation.
  4. Design of quantitative DUS
  5. How to read papers on quantitative DUS

 

TRAINER TEAM



Coordinator: Dr Eduard Diogène (from Universitat Autònoma de Barcelona)

Expert(s): Janice Fuller (from Amgen NV), Prof Joan-Ramon Laporte, Josep Maria Castel, Dr Xavier Vidal, Dr Imma Danés, Prof Carla Sans (from Universitat Autònoma de Barcelona), Prof Albert Figueras (from World Health Organization), Noah Jamie Robinson (from F. Hoffmann-La Roche Ltd), Dr Ulf Bergman (from Karolinska Institutet).

Intermediate level
75 h workload over 3 months (3 ECTS credits)
Key dates
Course calendar
Certificate award
or included in Master Year 2 or PhD programme
English language
Online based learning
Student: 1,500 €
Professional: 3,000 €
  Savings could be offered under eligibility conditions.

Applications currently closed

Application to this training will be available
from February 01st, 2021 to September 12th, 2021.
Thanks for applying during this period.

Contact the Eu2P Central Office

Applications will open on February 01st, 2021. Please contact the Eu2P Central Office for information.

Or include this module in your training curriculum choices...

Master Year 2 PhD



Confused? Read the FAQs...

NEED TO TALK TO US?

+33 6 30 29 00 29

Monday-Friday / 9.00am-6.00pm CET

 

Powered By

Eu2P Executive Board partners

Created By

Eu2P project consortium partners